Clinical Intervention:Molecular Targeted Drugs

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 13 total displayed.

Most recent content

Perspectives
Isolating the Effects of Social Interactions on Cancer Biology

Brian C. Trainor, Colleen Sweeney, and Robert Cardiff
Cancer Prevention Research 2009; 2: 843-846. [Abstract] [Full text] [PDF]  

Past content

Research Articles
Suitability of Self-Collected Vaginal Samples for Cervical Cancer Screening in Periurban Villages in Andhra Pradesh, India

A. Pavani Sowjanya, Proma Paul, Haripriya Vedantham, Gayatri Ramakrishna, D. Vidyadhari, K. Vijayaraghavan, Shantha Laksmi, Mrudula Sudula, Brigitte M. Ronnett, Manik Das, Keerti V. Shah, Patti E. Gravitt on behalf of the Community Access to Cervical Health Study Group
Cancer Epidemiol. Biomarkers Prev. 2009; 18: 1373-1378. [Abstract] [Full text] [PDF]  

Research Articles
Risk of Cardiovascular Events in a Randomized Placebo-Controlled, Double-Blind Trial of Difluoromethylornithine plus Sulindac for the Prevention of Sporadic Colorectal Adenomas

Jason A. Zell, Daniel Pelot, Wen-Pin Chen, Christine E. McLaren, Eugene W. Gerner, and Frank L. Meyskens
Cancer Prevention Research 2009; 2: 209-212. [Abstract] [Full text] [PDF]  

Research Articles
ESR1 Promoter Hypermethylation Does Not Predict Atypia in RPFNA nor Persistent Atypia after 12 Months Tamoxifen Chemoprevention

Joseph C. Baker, Jr., Julie H. Ostrander, Siya Lem, Gloria Broadwater, Gregory R. Bean, Nicholas C. D'Amato, Vanessa K. Goldenberg, Craig Rowell, Catherine Ibarra-Drendall, Tracey Grant, Patrick G. Pilie, Shauna N. Vasilatos, Michelle M. Troch, Victoria Scott, Lee G. Wilke, Carolyn Paisie, Sarah M. Rabiner, Alejandro Torres-Hernandez, Carola M. Zalles, and Victoria L. Seewaldt
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1884-1890. [Abstract] [Full text] [PDF]  

Research Articles: Therapeutics, Targets, and Development
Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase

Dhananjay P. Kunte, Ramesh K. Wali, Jennifer L. Koetsier, and Hemant K. Roy
Mol. Cancer Ther. 2008; 7: 1797-1806. [Abstract] [Full text] [PDF]  

Research Articles: Therapeutics, Targets, and Development
Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis

Irina V. Lebedeva, Zhao-zhong Su, Nichollaq Vozhilla, Lejuan Chatman, Devanand Sarkar, Paul Dent, Mohammad Athar, and Paul B. Fisher
Mol. Cancer Ther. 2008; 7: 2042-2050. [Abstract] [Full text] [PDF]  

Research Articles: Therapeutics, Targets, and Development
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes

Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, and Clinton J. Grubbs
Mol. Cancer Ther. 2008; 7: 972-979. [Abstract] [Full text] [PDF]  

Research Articles
Urinary 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine in Patients with Parasite Infection and Effect of Antiparasitic Drug in Relation to Cholangiocarcinogenesis

Raynoo Thanan, Mariko Murata, Somchai Pinlaor, Paiboon Sithithaworn, Narong Khuntikeo, Walaluk Tangkanakul, Yusuke Hiraku, Shinji Oikawa, Puangrat Yongvanit, and Shosuke Kawanishi
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 518-524. [Abstract] [Full text] [PDF]  

Research Articles
Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations

Joel M. Reid, Sumithra J. Mandrekar, Elsa C. Carlson, W. Scott Harmsen, Erin M. Green, Renee M. McGovern, Eva Szabo, Matthew M. Ames, Daniel Boring, Paul J. Limburg for the Cancer Prevention Network
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 674-679. [Abstract] [Full text] [PDF]  

Cancer Prevention
Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Jeffrey N. Weitzel, Saundra S. Buys, William H. Sherman, Anna Marie Daniels, Giske Ursin, John R. Daniels, Deborah J. MacDonald, Kathleen R. Blazer, Malcolm C. Pike, and Darcy V. Spicer
Clin. Cancer Res. 2007; 13: 654-658. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2